Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 6, 2004, Pages 1697-1702

  Hasegawa, Tomomi ^a   Yoshimura, Naoki ^a   Oka, Shigeteru ^a   Ootaki, Yoshio ^a   Toyoda, Yoshiya ^a   Yamaguchi, Masahiro ^a  

^a KOBE CHILDREN S HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; HEART FATTY ACID BINDING PROTEIN; TROPONIN T; UNCLASSIFIED DRUG;

ADOLESCENT; AORTA CLAMPING; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CONGENITAL HEART DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; HEART; HEART DISEASE; HEART MUSCLE INJURY; HEART SURGERY; HEMATOCRIT; HUMAN; INFANT; INFORMED CONSENT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN SECRETION;

EID: 2642588275     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.02.006     Document Type: Article

References (16)

1. Taggart DP, Hadjinikolas L, Wong K, Yap J, Hooper J, Kemp M, et al. Vulnerability of paediatric myocardium to cardiac surgery. Heart. 1996;76:214-7.
2. Lipshultz SE, Rifai N, Sallan SE, Lipsitz SR, Dalton V, Sacks DB, et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation. 1997;96:2641-8.
3. Suzuki K, Sawa Y, Kadoba K, Takahashi T, Ichikawa H, Kagisaki K, et al. Early detection of cardiac damage with heart fatty acid-binding protein after cardiac operations. Ann Thorac Surg. 1998;65:54-8.
4. Petzold T, Feindt P, Sunderdiek U, Boeken U, Fischer Y, Gams E. Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur J Cardiothorac Surg. 2001;19:859-64.
5. Toyoda Y, Yamaguchi M, Yoshimura N, Oka S, Okita Y. Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2003;125:1242-51.
6. Roe BB, Hutchinson JC, Ullyot DJ, Smith DL. Myocardial protection with cold, ischemic, potassium-induced cardioplegia. J Thorac Cardiovasc Surg. 1977;73:366-70.
7. Ohkaru Y, Asayama K, Ishii H, Nishimura S, Sunahara N, Tanaka T, et al. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Methods. 1995;178:99-111.
8. Kulik TJ, Moler FW, Palmisano JM, Custer JR, Mosca RS, Bove EL, et al. Outcome-associated factors in pediatric patients treated with extracorporeal membrane oxygenator after cardiac surgery. Circulation. 1996;94(9 Suppl):II63-8.
9. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s? Circulation. 1993;88:750-63.
10. Glats JF, Kleine AH, Van Nieuwenhoven FA, Hermens WT, Van Dieijen-Visser MP, Van der Vusse GJ. Fatty acid-binding protein as a plasma marker for the estimation for myocardial infarct size in humans. Br Heart J. 1994;71:135-40.
11. Schaap FG, van der Vusse GJ, Glatz JF. Fatty acid-binding proteins in the heart. Mol Cell Biochem. 1998;180:43-51.
12. Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asayama K, Kimura H, et al. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med. 2000;38:231-8.
13. Watanabe T, Ohkubo Y, Matsuoka H, Kimura H, Sakai Y, Ohkaru Y, et al. Development of a simple whole blood panel test for detection of human heart-type fatty acid-binding protein. Clin Biochem. 2001;34:257-63.
14. Fransen EJ, Maessen JG, Hermens WT, Glantz JF. Demonstration of ischemia-reperfusion injury separate from postoperative infarction in coronary artery bypass graft patients. Ann Thorac Surg. 1998;65:48-53.
15. Davies MJ, Nguyen K, Gaynor JW, Elliott MJ. Modified ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1998;115:361-70.
16. Leung JM, Weiskopf RB, Feiner J, Hopf HW, Kelley S, Viele M, et al. Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology. 2000;93:1004-10.